Gastric GATA-6 DNA-binding protein: proteolysis induced by cAMP  by Nakagawa, Reiko et al.
FEBS 18588 FEBS Letters 408 (1997) 301-305 
Gastric GATA-6 DNA-binding protein: proteolysis induced by cAMP 
Reiko Nakagawaa, Ryuichiro Satoa, Masamitsu Futaib, Hideyoshi Yokosawa0, 
Masatomo Maedaa'* 
"Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565, Japan 
bDivision of Biological Sciences, The Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka 567, Japan 
' Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo 060, Japan 
Received 10 March 1997; revised version received 7 April 1997 
Abstract The rat gastric GATA DNA-binding protein, GATA-
6 (GATA-GT1), was stably expressed in CHO-K1 cells. The 
GATA-6 protein was localized in the nucleus but not in the 
cytoplasm. Interestingly, when cells were treated with dibutyryl 
cAMP, the GATA-6 protein was specifically degraded. Such a 
phenomenon was not observed in the presence of 5'-AMP or 
dibutyryl cGMP. The cellular level of the GATA-6 protein was 
restored upon removal of dibutyryl cAMP. Degradation was also 
induced by cholera toxin, which increased the cellular cAMP 
concentration, and was inhibited by a protein kinase A inhibitor. 
However, activators of protein kinase C did not have any effect. 
The degradation was inhibited by proteasome inhibitors (PSI 
(benzyloxycarbonyl-Ile-Glu(O-i-Bu)-Ala-leucinal) and MG115 
(benzyloxycarbonyl-Leu-Leu-norvalinal)) but not by those of 
lysosomes and serine proteases. These results suggest that a 
kinase-mediated protein phosphorylation is the cellular signal for 
degradation of the GATA-6 protein. This finding constitutes a 
novel aspect of regulation by GATA DNA-binding proteins, 
which are essential for developmental processes and tissue-
specific transcription. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The G A T A transcription factors in vertebrates carry tan-
dem zinc fingers (Cys-X2-Cys-Xi7-Cys-X2-Cys)-X29-(Cys-
X2-Cys-Xi7-Cys-X2-Cys) in the central par t of the molecule 
[1]. Previously, the primary structures of six G A T A proteins 
were reported. They are divided into two groups: one 
(GATA-1 , GATA-2 and GATA-3) is mainly found in blood 
cells [2], and the other (GATA-4, GATA-5 and GATA-6) in 
the heart, gastrointestinal tract and other tissues [3,4]. These 
G A T A proteins are suggested to play important roles in tis-
sue-specific gene expression and developmental processes: the 
targeted disruption of the GATA-1 [5], GATA-2 [6], GATA-3 
[7], and GATA-4 [8] genes demonstrated that these genes are 
essential for embryogenesis. In each system, the remaining five 
G A T A protein genes could not compensate for the deleted 
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bonyl-Leu-Leu-norvalinal; TPA, 12-O-tetradecanoylphorbol 13-
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G A T A gene, indicating that the expression program for 
each G A T A protein could be tightly regulated in cell- and 
time-dependent manners. 
The tandem zinc fingers are highly conserved among these 
G A T A proteins, whereas their outside sequences are divergent 
[9], suggesting that they are responsible for the unique func-
tions in transcriptional regulation of each G A T A protein. We 
isolated GATA-4 and GATA-6 (previously named GATA-
GT2 and G A T A - G T 1 , respectively) c D N A clones from a 
rat stomach library in the course of a study on the cell-specific 
expression of the gastric proton pump [3]. The rat GATA-6 
has a unique serine residue (Ser-284) potentially phosphory-
lated by protein kinases A and C in the tandem zinc fingers. It 
is interesting to determine how the kinase(s) affect the func-
tions and cellular distribution of GATA-6. In this study, we 
prepared a stable cell line that expresses a truncated GATA-6 
(residues 51-441), and found that this protein was degraded in 
response to elevation of the cellular c A M P concentration. 
This phenomenon was examined in detail and its biochemical 
significance was discussed. 
2. Material and methods 
2.1. A stable CHO-cell line expressing GATA-6 
Rat GATA-6 cDNA (BstXI fragment encoding Met-51-Ala-441) 
[6] was inserted into the EcoKV site of pBluescriptSKII(+). The Bam-
HI-Kpnl fragment of the resulting plasmid was substituted with the 
EcoRl-Kpnl fragment of mammalian expression vector pcDL-SRoc 
(kindly provided by Dr. K. Maruyama, The Institute of Medical 
Science, The University of Tokyo). Deletion of the 50 amino-terminal 
residues did not affect the function of GATA-6, as judged with a 
reporter gene assay [10]. 
CHO-K1 cells [11] were cultured in F12 medium containing 7% (v/ 
v) fetal bovine serum (Gibco BRL, NY) at 37°C. A stable CHO clone 
expressing GATA-6 (tcl-17a) was isolated by introduction of the 
above expression plasmid (pSRoe-GTl') together with pMAMneo 
(CLONTECH, CA), in the ratio of 1/10 (w/w), and selection in the 
presence of 1 mg/ml G418 (Sigma, St. Louis, MO). A G418 resistant 
clone (n-5) carrying only pMAMneo was also isolated. 
2.2. Site-specific antibodies for GATA-6 
A 579 bp Hincll-EcoRl fragment encoding carboxyl terminal Thr-
383-Ala-441 of rat GATA-6 was inserted between the Smal and 
EcoRl sites of the pGEX-2T vector (Pharmacia Biotech, Uppsala). 
The construct was introduced into E. coli XL 1-Blue and then the 
fusion protein with glutathione S-transferase (GST) was purified on 
a glutathione affinity column (Pharmacia Biotech). A rabbit was im-
munized with the purified protein. The site-specific polyclonal anti-
bodies were purified by passing them through Affigel 10 (Bio-Rad, 
CA) conjugated with GST isolated from E. coli with pGEX-2T. 
2.3. Detection of GATA-6 in CHO cells 
Indirect fluorescence analysis was carried out by the published 
method [12]. Cells grown on glass coverslips were processed and 
then reacted with the above antibodies (1:1000 dilution), followed 
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by incubation with fluorescein isothiocyanate-conjugated goat anti-
rabbit IgG (1:500 dilution, Zymed Laboratories, San Francisco, CA). 
The whole-cell lysate and subcellular fractions (cytosol (postnuclear 
supernatant) and nuclear protein extracts prepared by the published 
method [13]) were subjected to SDS-polyacrylamide gel electrophore-
sis for protein staining [14] and Western blotting [15]. The proteins 
were electro-blotted onto nitrocellulose filters (Schleicher and Schüell, 
Dassel, Germany), and detected with an Amersham ECL e Western 
blotting analysis system (1:2000 and 1:5000 dilutions of the GATA-6 
antibodies and horseradish peroxidase-linked donkey anti-rabbit Ig, 
respectively). The intensities of the bands were determined using a 
NIH image analysis program. Gel-shift analysis involving a nuclear 
extract was carried out as described previously [16]. Protein was as-
sayed with a Bio-Rad Protein Assay [17], with bovine serum albumin 
(fraction V, Sigma) as a standard. 
2.4. Chemicals 
Restriction enzymes, T4 DNA ligase, calf intestine phosphatase and 
the Klenow fragment were obtained from Takara Shuzo (Kyoto), 
Toyobo (Osaka), New England BioLabs (Beverly, MA) or Nippon 
Gene (Toyama). dbcAMP and dbcGMP were obtained from Sigma 
and Yamasa (Chiba, Japan), respectively. Methylamine hydrochloride 
and chloroquine diphosphate were from Nacalai Tesque (Kyoto). 
Cholera toxin and cycloheximide were from Wako (Osaka). 
5'-AMP, IP3, K-252a and E-64d were supplied by Kohjin (Tokyo), 
Dojindo Lab. (Kumamoto), Kyowa Medex (Tokyo), and Taisho 
Pharmaceutical Co. (Tokyo), respectively. MG101, MG115 and PSI 
were purchased from Peptide Institute Inc. (Osaka). DOG and TPA 
were from Seikagaku-Kogyo (Tokyo) and Wako, respectively. 
All other chemicals used were of the highest grade commercially 
available. 
3. Results 
3.1. Expression of the GATA-6 DNA-binding protein in 
CHO-K1 cells 
We introduced an expression plasmid for gastric GATA-6 
into CHO-K1 cells and isolated several G418 resistant clones 
stably expressing this protein. GATA-6 was detected in the 
nuclear extracts from the resistant clones on gel shift analysis 
with site-specific antibodies (not shown). However, only one 
clone, tcl-17a, expressed enough GATA-6 to be detectable on 
Western blotting. We used this clone for further studies. 
GATA-6 was localized in the nucleus, as demonstrated by 
indirect immuno-fluorescence analysis (Fig. 1A). We also con-
firmed that GATA-6 was present in the nuclear protein ex-
tract, but not in the post-nuclear cytoplasmic fraction on 
Western blotting. The expression of GATA-6 affected neither 
the cell morphology nor growth behavior, such as the dou-
bling time and saturation density. It must be noted that we 
could not detect endogenous GATA-6 in the control cells (n-
5) on gel shift analysis (not shown) and indirect immuno-flu-
orescence analysis (Fig. 1C). 
3.2. Effect of dbcAMP on the cellular amount of GATA-6 
GATA-6 has a potential phosphorylation site (Ser-284) for 
a protein kinase A and a protein kinase C between the tandem 
zinc fingers [3,9], which prompted us to study the effects of 
Fig. 1. Effects of dbcAMP and a proteasome inhibitor on the nuclear localization of the GATA-6 protein. Cells, tcl-17a (A,B,D) and n-5 (C), 
were plated on coverslips and grown for 48 h, and then further incubated for 12 h without an addition (A,C), or with 2 mM dbcAMP (B) or 
2 mM rfécAMP plus 50 μΜ MG115 (D). The cells were fixed, and the GATA-6 protein was visualized by indirect fluorescence analysis using 
site-specific GATA-6 polyclonal antibodies and fluorescein isothiocyanate-conjugated anti-rabbit antibodies. 
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dbcAMP (a metabolically stable cAMP analogue) [18] on the 
function and intracellular localization of GATA-6. Surpris-
ingly, immunochemical analysis revealed that dbcAMP treat-
ment decreased the cellular amount of GATA-6 (Fig. IB). The 
effective concentration for disappearance of the GATA-6 was 
in the mM range (Fig. 2, top), and the decrease in GATA-6 
was time-dependent (half-life, about 6 h) (Fig. 2, middle). The 
observed change was reversible, since on removal of dbcAMP 
the initial expression level of GATA-6 was rapidly restored 
(Fig. 2, bottom). 
The decrease in GATA-6 was specific for dbcAMP, since 
similar concentrations of 5'-AMP and dbcGMP did not cause 
such a decrease (Fig. 3, top left). Treatment with cholera 
toxin, which is known to increase the cellular cAMP concen-
tration by stimulating adenylate cyclase [19], had similar effect 
to dbcAMP (Fig. 3, top right). Furthermore, the A kinase 
inhibitor, K-252a [20], abolished the effect of dbcAMP (Fig. 
3, middle). These results suggest that GATA-6 degradation 
was induced by elevation of the intracellular cAMP level 
and activation of protein kinase A. Chemicals which activate 
the protein kinase C pathway, such as IP3 [21], DOG [22], 
and TPA [23], did not affect the cellular amount of GATA-6 
(Fig. 3, bottom). The turnover of GATA-6 decreased 2-fold 
with dbcAMP: the half-lives of GATA-6 in the presence and 
absence of dbcAMP were 4 and 7 h, respectively, when 
GATA-6 degradation was followed in the presence of cyclo-
heximide (40 μg/ml). The degradation is specific for GATA-6, 
since the staining patterns of cellular proteins in the presence 
and absence of dbcAMP on gel electrophoresis were the same. 
3.3. Effects of protease inhibitors 
To determine what proteases participate in the observed 
phenomenon, we examined the effects of various protease in-
hibitors added to the culture medium together with dbcAMP. 
E-64d [24,25], and methylamine or chloroquine [26] did not 
have any effect, suggesting that neither serine proteases nor 
lysosomal proteases are involved in the degradation (Fig. 4, 
top). However, proteasome inhibitors (PSI and MG115) 
[24,25,27] prevented the degradation of GATA-6 (Fig. 4, bot-
tom middle and right). This was further confirmed by the 
nuclear localization of GATA-6 in the MG115-treated cells 
(Fig. ID). MG101 only partially prevented the degradation, 
possibly because its major target is calpain and not protea-
some [24] (Fig. 4, bottom left). 
4. Discussion 
Our results clearly suggested that GATA-6 was specifically 
degraded by proteasome. This phenomenon was induced by 
an intracellular signal transduction system related to a protein 
kinase A. Gastric GATA-6 plays a role in the transcriptional 
activation of the genes for proton pump subunits [9]. The acid 
secretion by the proton pump was stimulated by an increase in 
the cytoplasmic cAMP concentration through the G-protein-
coupled H2 receptor [28]. Thus, the loss of GATA-6 through 
its degradation induced by cAMP could be a kind of negative 
feedback mechanism for reducing the proton pump protein 
and hence acid secretion. 
Degradation of transcription factors by proteasome has 
Fig. 2. Detection of the GATA-6 protein in tcl-17a cells cultured in the presence or absence of décAMP. tcl-17a cells (1 X105 cells/6 cm diam-
eter dish) were plated and cultured for 24 h. Then they were incubated for 24 h in the presence of various concentrations of ¿ÄcAMP (top) 
and for the indicated time periods with 2 mM dbcAMP (middle). The cells incubated for 24 h with (+) or without (—) 2 mM ¡ftcAMP were 
further treated with (+) or without (—) 2 mM ¿/¿cAMP in fresh medium for 24 h (bottom). Whole-cell lysates (10 \ig protein) were subjected 
to SDS-polyacrylamide gel electrophoresis and Western blotting. The GATA-6 protein was reacted with site-specific GATA-6 polyclonal anti-
bodies and then detected by means of ECL. 
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Fig. 3. Effects of various compounds related to protein kinases on the cellular behavior of GATA-6. tcl-17a cells were treated with (ficAMP 
or related compounds, or cholera toxin for 24 h at the indicated concentrations (top). A protein kinase A inhibitor, K-252a, was added to the 
medium in the presence (+) or absence (—) of 2 mM décAMP (middle). The cells were cultured with compounds related to the protein kinase 
C activation pathway for 24 h (bottom). The GATA-6 protein was analyzed as described in the legend to Fig. 2. The slight decrease with 
¿ÄcGMP could be due to the presence of a small amount of mono butylic cAMP in the reagent. 
been reported for those playing roles in cell growth [29]. How- regulatory aspect of transcriptional factors. The contribution 
ever, our results suggest that the factors (GATA proteins) of proteasome to GATA-6 is different from that to NF-kB, 
involved in the processes of cell-specific gene regulation and since the phosphorylation of an inhibitory factor, ΙκΒ, triggers 
development are another type of substrates for proteasome. its degradation and the nuclear localization of an active form 
This novel finding seems to be unique, and constitutes a new of NF-κΒ from the cytoplasm [30]. 
Fig. 4. Effects of various protease inhibitors on degradation of the GATA-6 protein. tcl-17a cells were treated with each protease inhibitor at 
the indicated concentrations for 12 h in the presence (+) or absence (—) of 2 mM rfécAMP. The GATA-6 protein was analyzed as described in 
the legend to Fig. 2. 
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Two bands of GATA-6 were observed on gel electrophore-
sis in this study. However, the precursor-product relationship 
of the upper and lower bands was difficult to determine, since 
they behaved almost similarly under our experimental condi-
tions, except that the upper one was accumulated in MG115-
treated cells. These bands failed to react with specific mono-
clonal antibody for multi-ubiquitin chains [31], suggesting that 
they are not polyubiquitinated. Furthermore, the A kinase 
inhibitor, K-252a, did not affect the steady-state content of 
GATA-6 (Fig. 3, middle). Thus it would be interesting to 
determine the target site of protein kinase A and the degra-
dation signal on the GATA-6 protein. Further studies are 
required to see whether the full-length GATA-6 and other 
GATA proteins (GATA-l~-5) have similar properties. Ex-
periments along such lines are now in progress. 
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